Speakers Include
- David Brown (Pfizer, UK)
- Chun-wa Chung (GlaxoSmithKline,
UK)
- Tim Dafforn (University of Birmingham)
- Paul Emsley (York University, UK)
- Phil
Evans (MRC, Cambridge, UK)
- Annie Hassell (GlaxoSmithKline, US)
- Kim Henrick (EBI, Cambridge, UK)
- Sandra Jacob (Novartis, Switzerland)
- Joël Janin (CNRS, Gif-sur-Yvette,
France)
- Gerard
Kleywegt (Uppsala University, Sweden)
- John Ladbury (University College,
London)
- Victor Lamzin (EMBL, Hamburg, Germany)
- Tomas Lundqvist (Astra Zeneca, Sweden)
- Airlie McCoy (Cambridge University, UK)
- Kiyoshi Nagai (MRC, Cambridge)
- Martin Noble (Oxford University, UK)
- Ruth Nussinov (National Cancer Institute, Frederick,
US)
- Michael Rossmann (Purdue University,
US)
- Tom Terwilliger (LANL, Los Alamos, US)
